DOI: 10.1055/s-00000142

Frauenheilkunde up2date


Blackwell KL, Burstein HJ, Storniolo AM et al.
Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study.

J Clin Oncol 2012;
30: 2585-2592

Download Bibliographical Data